Overview

Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the effectiveness and acceptability of a 3-day missed period pill regimen.
Phase:
Phase 2
Details
Lead Sponsor:
Gynuity Health Projects
Collaborator:
Cuidado Integral de la Mujer, Gineclinic, S.C.
Treatments:
Levonorgestrel
Mifepristone